GSK's US president reports ADS acquisition under savings plan
GSK disclosed that its US president acquired 9.324 notional ADS at $51.21 on October 22, 2026 on the NYSE, Reuters reports.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Reuters reports, citing a regulatory notice released through RNS, that Maya Martinez-Davis, GSK's president for the US, disclosed a transaction in the company's American Depositary Shares. The trade took place on October 22, 2026 on the New York Stock Exchange. The price was $51.2100 per ADS and the volume was 9.324 notional ADS. The shares were credited to the executive's account in GSK's Executive Supplemental Savings Plan. This is an initial notification covering a single transaction with no aggregated data.
why it matters
Notifications of this kind are routine regulatory reports on managers' dealings. The trade was made within a savings plan rather than on the open market, so it carries little independent signal about GSK's share price. Investors usually treat such disclosures as background information, paying closer attention only when they recur or come alongside larger transactions.
tags
instruments
sources
- REG - GSK PLC - Director/PDMR Shareholding — Reuters, 26 October 2026 at 15:30 UTC
- REG - Hays PLC - Director/PDMR Shareholding — Reuters, 26 October 2026 at 16:50 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗